Skip to main content
Premium Trial:

Request an Annual Quote

KeyGene, AGI Ink Deal Covering Whole Genome Profiling Technology

NEW YORK (GenomeWeb News) – Agricultural genomics firm KeyGene and the Arizona Genome Institute today announced an agreement for the use of the Wageningen, Netherlands-based firm's Whole Genome Profiling method in sequencing-based physical mapping projects.

AGI will also market the WGP method as part of the deal, which provides the institute a method for assembling physical maps for internal research projects and customer projects. WGP maps serve as scaffolds in whole-genome sequencing projects, allowing researchers direct access to Bacterial Artificial Chromosomes (BAC), which contain genome segments of interest. The technology also can be used to ascertain structural genome changes in evolutionary studies and breeding programs, KeyGene and AGI said.

The WGP method uses next-generation sequencing to produce short-read sequences next to restriction enzyme recognition sites in BACs. The BACs are pooled, and BAC-pooled DNA are isolated based on protocols developed by KeyGene's co-marketing partner Amplicon Express.

"The WGP tags are used to assemble large numbers of BACs into a physical map of overlapping clones," KeyGene said in a statement. "Integration of whole-genome sequence data with the WGP map results in super scaffolds with superior assembly metrics."

Financial and other terms of the deal were not disclosed.

"Once WGP is established in our institute we will immediately apply it to our ongoing work to sequence the collective Oryza and Brassicales genomes on our quest to help solve the 9 billion people question — which is how can we grow enough food to feed an additional 2 billion inhabitants in less than 40 years," Rod Wing, director of AGI at the University of Arizona, said in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.